Spinal cord injury represents a serious medical problem, and leads to chronic conditions that cannot be reversed at present. It has been suggested that trophic factor treatment may reduce the extent of damage and restore damaged neurons following the injury. We have tested the effects of osteogenic protein-1 (OP-1, also known as BMP-7), a member of the transforming growth factor-P superfamily of growth factors, on developing spinal cord motor neurons in an intraocular transplantation model. Embryonic day 13 or 18 spinal cord tissue was dissected, incubated with OP-1 or vehicle, and injected into the anterior chamber of the eye of adult rats. Injections of additional doses of OP-1 were performed weekly, and the overall growth of the grafted tissue was assessed noninvasively. Four to 6 weeks postgrafting, animals were sacrificed and the tissue was processed for immunohistochemistry using antibodies directed against choline acetyltransferase, neurofilament, and the dendritic marker MAP-II. We found that OP-1 treatment stimulated overall growth of spinal cord tissue when dissected from embryonic day 18, but not from embryonic day 13. OP-1 treatment increased cell size and extent of cholinergic markers in motor neurons from both embryonic stages. The neurons also appeared to have a more extensive dendritic network in OP-1-treated grafts compared to con trols. These findings indicate that OP-1 treatment may reduce the extent of axotomy-induced cell death of motor neurons, at least in the developing spinal cord.
INTRODUCTION
Members of the transforming growth factor-P (TGF-P) superfamily of proteins, including activins and bone morphogenetic proteins (BMPs), comprise an evolutionarily well-conserved group of proteins that controls dif ferentiation, cell growth, and morphogenetic processes in a number of different systems during development (30, 36) . The BMPs, which comprise a subgroup of the TGF-ps, have been shown to affect embryonic skeletal development (9, 37) , musculoskeletal neoplasms (41) , tooth formation, in particular dentinogenesis (23) , as well as renal branching morphogenesis (8, 34) . Osteoge nic protein-1 (OP-1, also known as BMP-7) was first isolated from extracellular bone matrix, based on its ability to induce new bone formation in vivo (36) . Mem bers of the TGF-p superfamily encode secreted proteins that share common structural features. They are proteolytically processed from the precursors to yield a carboxy-terminal mature protein varying from 110 to 150 amino acids. All members share a conserved pattern of cysteines in this domain. The active ligand form is a disulfide-bonded homodimer of a single family member or a heterodimer of two different members [see (16, 30, 31) ]. In comparison to other TGF-p superfamily mem bers, OP-1 was shown to differentially regulate progres sion of the osteogenic lineage (9) . A number of studies have shown that OP-1 can induce the formation of new bone when placed in a bony environment (9, 12, 36, 37) .
The TGF-Ps and BMPs selectively signal to the re sponding cells through oligomeric complexes of type I and type II serine/threonine kinases (27, 32, 39) . It was recently demonstrated that cells in the central nervous system (CNS) express high levels of BMP receptor type II, suggesting that BMPs may serve functions in the ma ture CNS. During early development of the neural sys tems, BMPs have been shown to play a role in neurulation and dorsoventral patterning of the neural tube as well as promoting the generation of astrocytes and radial glia [ (6, 17, 18) ; see also (32) ]. During later stages of neural differentiation, BMPs potentiate the survival of regional neuronal phenotypes and enhance the out growth of dendritic processes (24, 25, 32, 35, 42) . The spe cific role of OP-1 versus other BMPs in these processes has not yet been elucidated. OP-1 has, for example, been shown to induce dendritic growth in cultured sympa thetic neurons (24) . These authors reported that OP-1 treatment of these cultures elicited an extensive dendritic response that correctly segregated and formed synaptic contacts of appropriate polarity (24) . With the addition of nerve growth factor (NGF) to the culture, OP-1 in duced dendritic growth on perinatal sympathetic neurons comparable to that observed in situ. These findings sug gested that OP-1 might also be used as a dendritic growth promoter for other neuronal populations, such as the dorsal root ganglion or spinal cord motor neurons. Indirect evidence for OP-1 effects on spinal cord devel opment was provided by Soderstrom et al. (39) , who demonstrated that mRNA for the OP-1 receptor BMPR-II was present in spinal cord during embryonic develop ment. These authors demonstrated strong BMPR-II mRNA expression in spinal cord, dorsal root ganglia, and spinal nerves at embryonic day 16, and with marked labeling maintained in the spinal cord and dorsal root ganglia at embryonic day 21 in the rat (39) . These find ings suggest that spinal cord neurons would be respon sive to treatment with OP-1, at least during embryonic development.
Classic work using animal models and tissue culture has identified many different trophic molecules that have effects on spinal cord motor neuron survival and/ or differentiation. For example, several members of the neurotrophin family of trophic factors have been found to stimulate spinal cord neuronal survival and differenti ation, including brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) [see (7, 10, 11, 19) ]. Ciliary neurotrophic factor (CNTF) has also been found to pre vent degeneration of adult motor neurons after axotomy (5, 38) . The members of the neurotrophin family have so far been the best candidates for treatment of spinal cord injury in the clinic, but, surprisingly, inactivation of their receptor genes leads to only partial loss of motorneurons, suggesting that other factors may be involved in motor neuron survival during development and repair [see, e.g., (5) ]. We and others have previously shown that TGF-P superfamily members can promote survival and differentiation of spinal cord motor neurons, both in culture and in vivo. Glial cell line-derived neurotrophic factor (GDNF), another member of the TGF-P superfamily of growth factors (28) , was found to support the survival of purified rat motor neurons in culture (20, 43) as well as to prevent axotomy-induced cell death in adult spinal cord and brain stem motor neurons (20, 26) . In addition, we have previously shown that GDNF, when injected directly into the intraocular fluid (40) or admin istered using a novel carrier-mediated transport with transferrin receptor conjugates (1), can enhance survival of spinal cord tissue transplanted to the anterior chamber of the eye. The intraocular transplantation technique has been used extensively to evaluate trophic factor efficacy, because tissue can be observed noninvasively and longi tudinally to assess growth and vascularization [see (2, 14, 40) ]. We have demonstrated that CNS tissue will survive transplantation and develop normal vasculariza tion with a functional blood-brain barrier (15) and that spinal cord transplants develop many physiological and morphological characteristics of the mature spinal cord neurons in situ (21, 22) .
The studies of GDNF effects on spinal cord trans plants and the temporo-spatial distribution of OP-1 and its receptors (39) prompted us to investigate the effects of OP-1 on spinal cord transplants. The specific aim of the present study was to determine if OP-1 could en hance survival of fetal spinal cord tissue in the anterior chamber of the eye. We utilized tissue from two differ ent fetal stages, embryonic day 13 and 18, to determine whether we could expand the developmental window for transplantation of spinal cord tissue. Fetal spinal cord tissue is known to survive transplantation only when ob tained from immature developmental stages, earlier than embryonic day 15 in the rat (22) .
MATERIALS AND METHODS

Transplantation and Intraocular Injections
Spinal cord tissue from two different embryonic stages (embryonic day = El3 and El8), determined by the crown-rump length of the fetus, was dissected from the cervical portion of the spinal cord of fetuses from timed pregnant Fischer 344 rats, as previously described (21) . Ten animals with bilateral transplants were used for the El8 donor stage (10 transplants in each group), and 20 animals, performed at two different occasions ( fied syringe (13) . Transplants were allowed to mature for 4-6 weeks postgrafting, during which time weekly measurements were made through the translucent cornea with a stereoscopic microscope to establish growth curves. The measurements represented the area of each transplant, as previously described [see, e.g., (2, 13, 14) ]. Because individual transplant size may vary (tissue pieces of fetal tissue at an exactly similar size are diffi cult to obtain, especially when using whole slices of spi nal cord from two different donor stages), we normal ized the transplant growth, so that each value shown in Figure 1 represents the growth of that particular trans plant, expressed as increase over initial size (= 1.0). This way, it is possible to evaluate differences between growth of spinal cord from different donor stages, which have different initial size. Beginning 1 week postgrafting, weekly intraocular injections of the same com pounds were performed (1 ug of OP-1 per injection in 5 ul vehicle). The dosage chosen for OP-1 preincubation and intraocular injections was based upon previous work using GDNF and intraocular spinal cord grafts (40), as well as previous data on OP-1 treatment of neurons in tissue culture (24, 25, 35, 42) . Statistical analysis of the transplant size was performed using weeks 0-4 as re peated measures (ANOVA) to determine the growth rate over time. The curves were fit by polynominal regres sion and the Scheffe test was employed to account for the multiple comparisons made at each of the weeks.
Immunohistochemistry
Transplants were dissected from the host iris and pro cessed for immunohistochemistry to determine the ap pearance of motor neurons in the spinal cord tissue. The transplants were immersion fixed overnight in paraform aldehyde (4%). They, were transferred to 30% sucrose in phosphate buffer (PB) for at least 16 h, after which they were sectioned at 8-12 um on a cryostat (Zeiss/Microm, Carl Zeiss Inc., Tempe, AZ). Every 10th section was collected for routine histology, using cresyl violet stain ing on glass slides. The sections used for immunohisto chemistry were mounted on slides and rinsed in phos phate-buffered saline (PBS) containing 0.05% Triton X-100. Sections were then incubated 48 h with antibodies directed against choline acetyltransferase (ChAT, Boehringer-Mannheim, dilution 1:20), the dendritic marker MAP-II (Sigma, 1:100), and neurofilament (NF, 1:100, Dakopatts). The antibodies were diluted in PBS with 1% normal goat serum and 1% serum albumin to reduce background staining. The sections were rinsed in PBS and incubated with anti-rabbit (ChAT and MAP-II) or antimouse (NF) IgG conjugated to fluorescein isothiocyanate (FITC, 1:100; Vector Laboratories Inc., Burlingame, CA). They were studied in a Nikon Optiphot mi croscope (Nikon, Tokyo, Japan). Specificity controls included sections where the first or second antibody was omitted. When the terms "-immunoreactive" or "-posi tive" are used in the text, this always means "like immu noreactivity." because the indirect immunohistochemis try techniques used in the study cannot directly verify the identity of tissue antigens.
Image Analysis
The sections labeled with ChAT, NF, and MAP-II antibodies were studied in terms of overall staining in tensity and cell size, using an image analysis system dis tributed by the National Institutes of Mental Health (NIH Image). The Nikon Optiphot microscope was con nected to a Macintosh Quadra computer by means of a Cohu analog video camera (model 4990) and an analog/ digital card. Images were collected with the video cam era using the lOx objective and measurements of overall staining intensity and the average size of immunoreac tive neurons were obtained from every fifth section for each antibody throughout each transplant. The staining intensity measurements were analyzed after background fluorescence had been subtracted from each section, to control for differences that might occur due to different thickness of individual sections, etc. The mean size and staining intensity was determined for each animal and the mean of means used as a group value for the two different groups examined. Statistical analysis of mea surements was performed using two-way Student's ttests. For further details on this image analysis system see 
RESULTS
Overall Growth of Spinal Cord Transplants
When tissue from El8 was used, there was a signifi cant difference in the growth of spinal cord tissue in response to OP-1 (Fig. la) . Very few control grafts con tained surviving tissue at all after 2 weeks in oculo, compared to the OP-1-treated group where a more ro bust survival was seen (an anterior eye chamber with only remnants of a control graft is shown in Fig. 2b , versus a healthy and fairly large transplant, treated with OP-1, in Fig. 2a ). As can be seen in Figure 1 , the OP-1treated grafts grew significantly larger than the controls throughout the experiment. Only 50% of the transplants (5 of 10 total transplants) survived at all in the control group from donor age El8, whereas 90% (9 of 10 trans plants) survived in the OP-1-treated group. Statistical analysis with multiple comparisons (ANOVA with Scheffe test) revealed significance between the two groups in terms of overall tissue growth at 2, 3, and 4 weeks postgrafting (see Fig. la ). In additional experi ments, we transplanted spinal cord tissue from E13 and treated the tissue with either OP-1 or vehicle. As can be seen in Figure lb , there was no significant difference in terms of overall tissue growth between the groups in transplants from donor stage El3. From this donor stage, 80% of the transplants in the control group survived (16 
General Histology
Transplants from both groups were sectioned and prepared for routine histology using cresyl violet stain ing. The OP-1-treated grafts appeared to contain a greater density of large neuronal cell bodies than control grafts (Fig. 3) . Quantitative image analysis of cell body size revealed a 45% increase in the mean diameter of neuronal cell bodies in the OP-1-treated groups com pared to controls (mean ± SEM values for overall cell size were 355 ± 26 um 2 for the OP-1 group; n = 9, and 245 ± 45 urn 2 for the control group; n -5). Statistical analysis between the two different groups (two-way Stu dent's f-test) revealed a significant difference at the level of p < 0.05. Other components of the transplants ap peared normal and similar between the two groups, such as vascularization.
Immunohistochemistry
Image analysis of sections stained with immunohisto chemistry did not reveal any differences in terms of overall staining densities between the OP-1 groups from E13 or El 8 donor stages, or between controls grafts from these two different stages. Due to the poor survival rate of control transplants, the different image analysis mean values were therefore pooled between the two control groups, from El3 and El8, as well as the two OP-1 groups, from E13 and E18. However, incubation of the transplanted tissue with antibodies directed against ChAT revealed a significant difference in both appearance and density of staining between groups of animals treated with OP-1 versus control solution, re gardless of donor stage ( Fig. 4a-d) . The same magnitude of difference between the OP-1-treated group and the control group was seen at both the El3 and the El 8 donor stages. Moreover, individual neurons were larger and exhibited significantly more extensive neurite branching. This was confirmed by quantitative image analysis of the overall ChAT staining density (Fig. 5a ).
The mean ± SEM staining density was 1.45 ± 0.04 for the OP-1-treated group (n = 7; staining/background ra tio; p < 0.01) and 1.21 ± 0.07 for the control group (n = 6). In contrast to the enhanced cholinergic markers, there was no statistical difference between the two groups, with respect to staining density for neurofila ment, even though there was a trend towards an increase in the OP-1 group (Figs. 5b and 6a, b) . The mean ± SEM staining/background ratio for neurofilament immunohis tochemistry was 1.20 ± 0.05 for the OP-1 group (n = 1) and 1.0410.01 for the control group (n = 6). Sections were also stained for the dendritic marker MAP-II ( Figs.   5c and 6c, d ). There was a significant difference in the appearance, but not in staining density, of MAP-II-immunoreactive profiles in the two groups (see Fig. 6c,   d ). When overall staining density measurements were performed over the whole transplant area, there was no difference in the staining/background ratio of MAP-II staining (Fig. 5c ). The mean ± SEM value for MAP-II staining was 1.19 + 0.01 (n = 7) in the OP-1 group, and The areas with significant dendritic branching in OP-1treated grafts (Fig. 6c ) contained a higher density of MAP-II-immunoreactive profiles, which also appeared to be more developed in terms of thickness and branching, than similar areas in the vehicle-treated grafts ( Fig. 6d ).
DISCUSSION
We have demonstrated that OP-1 stimulates choliner gic and dendritic markers in embryonic spinal cord tis sue grafted into the anterior chamber of the eye of the adult rat. There was an increase in the overall graft sur vival of spinal cord transplants with OP-1 when donor tissue was obtained from El8, but not when transplants were obtained from El3. The number of surviving trans plants in the OP-1-treated group was significantly greater than in the control group when El 8 tissue was used. These findings are in agreement with earlier stud ies, which have reported enhancement of dendritic pro cesses in sympathetic neurons in culture with OP-1 (25) and also a dendritic growth enhancement in hippocam pal cultures (42) . We only saw MAP-II staining in por tions of the grafts where neuronal cell bodies were lo cated. This is not surprising, because motor neurons appear only in the gray matter of the spinal cord, and the grafted tissue consisted of a complete section of fetal spinal cord tissue. It is difficult to perform an unbiased measurement of dendritic branches in the two groups, and no overall differences could be detected using image analysis of staining densities of MAP-II in whole sec tions of transplants. However, as demonstrated in Figure   6 , we found a qualitative difference in MAP-II staining in areas of neuronal cell bodies in the group treated with OP-1 compared to controls.
It was interesting to note that an OP-1 enhancement of overall tissue growth could be seen in transplants from donor stage 18, and not from El3 transplants.
There are several possible explanations for this phenom enon. First, we have previously shown that E18 spinal cord transplants survive poorly when transplanted to the anterior eye chamber (22) . In the present study, only 50% of the control grafts survived when donor tissue from El 8 was used, compared to 80% survival in the El3 control group. Embryonic day 13 spinal cord tissue has a much greater survival capacity and develops into larger transplants expressing organotypic morphological and physiological features of spinal cord neurons in situ (21, 22) . Thus, it is likely that the differences in OP-1 response seen between the two different donor stages may be due to the fact that the control grafts in the El3 There was a significant difference between OP-1 and control groups in terms of ChAT immunostaining (a; p < 0.01), but there was no significant difference between the two groups in terms of neurofilament staining (b). The overall MAP-II stain ing density was similar between the two groups (c). tion factors. Perides and his collaborators (33) found that OP-1 administration to neuroblastoma and glioma hy brid cells gave rise to a significant and long-lasting upregulation of all three major isoforms of neural cell adhesion molecules (N-CAM). Because this cell adhe sion molecule has been shown to be involved in neurite outgrowth and synaptogenesis [see (29) ], it is possible that the dendritic enhancement seen in our study and others may be mediated by the effect on cell adhesion molecules such as N-CAM. It would be interesting to examine the signaling cascades of BMPs and how they interact with the signaling cascades of the adhesion mol ecules. BMP ligands exhibit cooperative binding to dis tinct classes of type-I (BMPR-I) and type-II (BMPR-II) receptor subunits with transphosphorylation of the type I subunit by the type II receptor, and subsequent intra cellular signaling (32) . Different BMPs exhibit distinct profiles of receptor subunit binding; different cell types can display alternative patterns of receptor binding, and thus display a differential response pattern to the differ ent BMPs (32) . One current hypothesis for the BMP sig naling cascade holds that the activation of the BMPR-I subunit results in recruitment and phosphorylation of SMAD1 (a member of the MAP kinase family), which acts as a latent transcription factor. Activated SMAD1 subsequently associates with SMAD4 and the complex translocates to the nucleus where it associates with gene products to activate developmental stage-specific genes (32) . It is not known which developmental genes acti vate dendritic outgrowth, or if these gene products are closely associated with, for example, adhesion molecule synthesis and/or activation. Nevertheless, further studies are needed to determine if there is a specific BMP sig naling cascade in the neuron, separate from those de scribed for traditional growth factors. Because most TGF-ps utilize serine/threonine kinase receptors (27, 32, 39) as opposed to the tyrosine kinase receptors previously described for the neurotrophins (3,5,7), it is not likely that identical intracellular second messenger cascades are involved in these two different superfamilies of trophic factors, but it is interesting that they may act simultaneously on selective phenotypes of develop ing neurons.
We have previously found that GDNF stimulates sur vival of motor neurons in spinal cord transplants (1, 40) . Because this TGF-p superfamily member appears to ex hibit different signaling cascades and different receptor profiles than the BMPs, it would be interesting to per form a combined treatment of spinal cord transplants with both OP-1 and GDNF. This combination may en hance differentiation of the motor neurons (GDNF) as well as dendritic outgrowth and cholinergic markers (OP-1). Such combination treatments are predicted to have more robust effects for clinical purposes than any Figure 6 . Immunohistochemistry for neurofilament (a, b) and MAP-II (c, d). There was a tendency towards an overall increase in neurofilament staining between OP-1 (a) and control grafts (b) as is illustrated in this microphotograph. Overall neurofilament immunoreactivity appeared denser in the OP-1 grafts than in controls. The same pattern was seen with the dendritic marker MAP-II (c, d). Much denser staining for MAP-II was seen in areas of OP-1-treated grafts that contained cell bodies (see left side of c), whereas there was a more sparse staining in controls (d). Scale bar represents 20 um. trophic factor alone, because trophic factors exhibit spe cific and differential effects on separate components of neural development and plasticity. The two factors may act on the same cells or could act on different cells in the same transplant. It would also be interesting to deter mine if OP-1 is effective in treatment of the adult, in jured spinal cord, even though expression of its recep tors is known to decrease in late embryonic development (39) . Importantly, it is not yet known if OP-1 or its re ceptors are upregulated in response to injury in the adult spinal cord. These complexities notwithstanding, our data do document a significant positive effect of OP-1 on spinal cord tissues, both in terms of survival and neurite development.
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